(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
Live Chart Being Loaded With Signals
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia...
Stats | |
---|---|
今日成交量 | 170 273 |
平均成交量 | 40 708.00 |
市值 | 38.09M |
EPS | $0 ( 2024-05-03 ) |
下一个收益日期 | ( $-0.290 ) 2024-05-23 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.730 |
ATR14 | $0.00500 (0.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-11 | Wilson John J. Addington | Sell | 9 569 | Class A Common Stock |
2024-03-11 | Vezina Victoria | Sell | 5 435 | Class A Common Stock |
2024-03-11 | Wirtjes Sean M | Sell | 7 454 | Class A Common Stock |
2024-03-11 | Spignesi Robert G. Jr. | Sell | 10 323 | Class A Common Stock |
2024-02-12 | Wilson John J. Addington | Sell | 5 809 | Class A Common Stock |
INSIDER POWER |
---|
91.51 |
Last 96 transactions |
Buy: 3 823 953 | Sell: 95 953 |
音量 相关性
Rapid Micro Biosystems, 相关性 - 货币/商品
Rapid Micro Biosystems, 财务报表
Annual | 2023 |
营收: | $22.52M |
毛利润: | $-5.49M (-24.36 %) |
EPS: | $-1.220 |
FY | 2023 |
营收: | $22.52M |
毛利润: | $-5.49M (-24.36 %) |
EPS: | $-1.220 |
FY | 2022 |
营收: | $17.13M |
毛利润: | $-8.54M (-49.85 %) |
EPS: | $-1.430 |
FY | 2021 |
营收: | $23.23M |
毛利润: | $-7.74M (-33.32 %) |
EPS: | $-1.901 |
Financial Reports:
No articles found.
Rapid Micro Biosystems,
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。